Combination drug therapy effectively treats male infertility
(Wiley) Two drugs that are commonly used off-label in the treatment of male infertility are clomiphene citrate (CC) and anastrozole (AZ); however, data are lacking on the use of combination CC+AZ therapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2018 Category: International Medicine & Public Health Source Type: news
Aromasin vs Arimidex – Which Is Best To Use On-Cycle?
When using anabolic steroids to add bulk, to improve your performance, or even to maintain muscle mass while you melt away unwanted fat, it is vital to understand how that steroid works and whether it converts to estrogen in your body. The vast majority of steroids do require treatment with an aromatase inhibitor like Aromasin...
The post Aromasin vs Arimidex – Which Is Best To Use On-Cycle? appeared first on Anabolicco. (Source: eHealth News EU)
Source: eHealth News EU - April 25, 2018 Category: Information Technology Authors: Team Anabolicco Tags: Articles Source Type: news
Anastrozole vs. Letrozole
Title: Anastrozole vs. LetrozoleCategory: MedicationsCreated: 12/14/2017 12:00:00 AMLast Editorial Review: 12/14/2017 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - December 14, 2017 Category: Drugs & Pharmacology Source Type: news
Only 2 Years of Extended Anastrozole Needed in Breast Cancer Only 2 Years of Extended Anastrozole Needed in Breast Cancer
After an initial 5 years of endocrine therapy in postmenopausal cancer, a further 2 years of the aromatase inhibitor is sufficient, instead of another 5 years, suggest new results.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 8, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
SABCS: Two Years of Anastrozole Sufficient in HR + Early Breast CA
No significant difference in DFS for women receiving anastrozole for two, five years after endocrine tx (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 8, 2017 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Conference News, Source Type: news
Breast cancer screening has ‘little impact’ on cancer deaths
Over-diagnosis of cases is rising, warns study Related items fromOnMedica Experts recommend anastrozole for postmenopausal women with family history of breast cancer The genetics of breast cancer NICE approves breakthrough breast cancer drugs Breast cancer screening Breast cancer screening reduces risk of death (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 6, 2017 Category: UK Health Source Type: news
NICE approves breakthrough breast cancer drugs
New class of cancer treatment drugs approved for NHS Related items fromOnMedica The genetics of breast cancer Ovarian cancer drug may help stall breast cancer Experts recommend anastrozole for postmenopausal women with family history of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 16, 2017 Category: UK Health Source Type: news
Genetic test may help fight secondary breast cancer
Study shows benefits of using bone strengthening drugs Related items fromOnMedica Big data advances breast cancer research by ‘decades’ Experts recommend anastrozole for postmenopausal women with family history of breast cancer Women with incurable breast cancer receiving insufficient care Research reveals age-specific cancer risk with BRCA1/2 The genetics of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - October 24, 2017 Category: UK Health Source Type: news
NICE set to approve trastuzumab emtansine for breast cancer
NHS England will routinely fund Kadcyla for people with advanced HER-2 positive cancer Related items fromOnMedica Ovarian cancer drug may help stall breast cancer The medicine price debate Breast cancer drug ‘too costly’ for NHS Experts recommend anastrozole for postmenopausal women with family history of breast cancer Cancer-preventing drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 16, 2017 Category: UK Health Source Type: news
Ovarian cancer drug may help stall breast cancer
Trial results with olaparib are ‘encouraging’ Related items fromOnMedica Breast cancer Big data advances breast cancer research by ‘decades’ Women with incurable breast cancer receiving insufficient care Cancer-preventing drugs Experts recommend anastrozole for postmenopausal women with family history of breast cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - June 5, 2017 Category: UK Health Source Type: news
NICE: anastrozole for some women at risk of breast cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - April 1, 2017 Category: Drugs & Pharmacology Source Type: news
Experts recommend anastrozole for postmenopausal women with family history of breast cancer
Doctors should offer it to women at moderate risk of breast cancer Related items fromOnMedica Fertility treatments may impact on breast cancer risk Work needed to boost GPs ’ knowledge of cancer drug Cancer-preventing drugs (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 23, 2017 Category: UK Health Source Type: news
Arimidex (Anastrozole) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - January 17, 2017 Category: Drugs & Pharmacology Source Type: news
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
This research has been highlighted as a practice changing update by DynaMed Plus. It concludes that Fulvestrant has superior efficacy and is a preferred treatment option for patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not received previous endocrine therapy compared with a third-generation aromatase inhibitor, a standard of care for first-line treatment of these patients (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 4, 2017 Category: Consumer Health News Source Type: news
NHS to offer breast cancer prevention treatment pill for 4p-a-day
Prescribing watchdogs the National Institute for Health and Care Excellence said the drug, anastrozole, should be available to women who are over 50 and deemed to have a high risk. (Source: the Mail online | Health)
Source: the Mail online | Health - December 4, 2016 Category: Consumer Health News Source Type: news
